China: NMPA issues administrative measures for the recordation and inspection of general cosmetics

On January 13, 2023, China's National Medical Products Administration (NMPA) issued "Announcement on Matters Related to the Optimization of Administrative Measures for the Recordation and Inspection of General Cosmetics" with an aim to further optimize the administrative measures for the filing and inspection of ordinary cosmetics. This announcement grants conditional permission to notifiers or entrusted manufacturers of Chinese domestic low-risk cosmetics to conduct self-testing and submit the product self-testing reports as part of notification dossiers. From the date of issuance of this announcement, if inspection methods are adopted as quality control measures for ordinary cosmetics and the production link has been included in the daily supervision scope of the provincial drug regulatory department, and the product safety risk assessment results can fully confirm the safety of the product, the recordator may submit an inspection report carried out by the cosmetics recordator or the entrusted manufacturer in accordance with the relevant requirements of the cosmetics technical specifications when filing the product (with exception of certain cases). If a product submits a self-inspection report at the time of filing, the recordator shall also submit a statement of the corresponding inspection capabilities of the cosmetics filing and inspection stipulated in the "Specifications for Cosmetics Registration and Filing and Inspection Work", provide a description of the corresponding inspection personnel, equipment, facilities and site environment to carry out the self-inspection, and promise to be responsible for the authenticity and accuracy of the inspection report.